NCT00870480View on ClinicalTrials.gov

A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
Healthy
Interventions
DRUG

Finasteride 5 mg Tablet, single dose

A: Experimental Subjects received Intas Pharmaceuticals Ltd, India formulated products under fasting conditions

DRUG

Proscar® 5 mg Tablet, single dose

B: Active comparator Subjects received Merck Sharp and Dohme, U.S.A formulated products under fasting conditions

Trial Locations (1)

G 1 V 2K8

SFBC Anapharm, Sainte-Foy

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT00870480 - A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter